NCOG-18. PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE

BACKGROUND: Cognitive deficits both prior to therapy and during treatment have been documented within the glioblastoma (GBM) population. As more effective therapies arise, the options to explore lasting cognitive effects broaden. Based on pre-clinical data demonstrating synergism with radiation (RT)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Loughan, Ashlee, Shafer, Danielle, Lanoye, Autumn, Braun, Sarah, Dent, Paul, Malkin, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693109/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.579
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados